Filing Details
- Accession Number:
- 0000950170-24-104439
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-06 17:14:54
- Reporting Period:
- 2024-09-05
- Accepted Time:
- 2024-09-06 17:14:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1785279 | Metagenomi Inc. | MGX | Biological Products, (No Disgnostic Substances) (2836) | 813909017 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1995657 | Pamela Wapnick | C/O Metagenomi, Inc. 5959 Horton Street, 7Th Floor Emeryville CA 94608 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-09-05 | 6,265 | $2.88 | 63,051 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.
- The shares were sold in multiple transactions ranging from $2.80 to $2.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shars sold at each price.